Molly Parker, DO
Family Medicine · Jonesville, MINPI 1992074231
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,490 of the $24,009 with a category attached, or 81.2%. Boehringer Ingelheim accounts for 95.5% of it on its own, with 17 other manufacturers making up the rest. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $233.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$23K
- Novo Nordisk$256
- Johnson & Johnson$227
- AbbVie$161
- Actelion Pharmaceuticals US, Inc.$72
- Dexcom, Inc.$65
- plus $293 from 12 others
What the payments were for
- Consulting fees$19,49081%
- Travel & lodging$3,23213%
- Food & beverage$1,2875%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 28 | $22,934 |
| Novo Nordisk | 17 | $256 |
| Johnson & Johnson | 21 | $227 |
| AbbVie | 9 | $161 |
| Actelion Pharmaceuticals US, Inc. | 4 | $72 |
| Dexcom, Inc. | 4 | $65 |
| Lilly USA, LLC | 4 | $53 |
| Amarin Pharma, Inc. | 3 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Merck | 2 | $34 |
| Amgen | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| AstraZeneca | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$17,840
How this compares
$24,009 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $31,644 |
| XareltoRivaroxaban | 19 | $29,345 |
| OzempicSemaglutide | 26 | $24,235 |
| FarxigaDapagliflozin Propanediol | 22 | $23,415 |
| EliquisApixaban | 16 | $14,392 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $12,141 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $11,796 |
| TrulicityDulaglutide | 12 | $11,062 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,070 |
| Levothyroxine Sodium | 283 | $3,848 |
| Atorvastatin Calcium | 252 | $3,682 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,228 |
| Bupropion XlBupropion Hcl | 46 | $2,170 |
| Losartan Potassium | 154 | $2,136 |
| Metoprolol Succinate | 123 | $1,937 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $227 | $29,34519 claims |
| Novo NordiskOzempic | $256 | $24,23526 claims |
| AstraZenecaFarxiga | $12 | $23,41522 claims |
| Lilly USA, LLCTrulicity | $53 | $11,06212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Jonesville
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.